Developing innovative models of care to help improve access to quality and effective specialist eye care in underserved communities of regional and rural areas.
Overcoming barriers to discovering new treatments for age-related macular degeneration (AMD), accelerating the development and testing of new treatments in clinical trials.
Macular Disease Foundation Australia (MDFA) has awarded a total of $300,000 to two groundbreaking research projects.
As part of our 25th anniversary celebrations, we’re excited to introduce the MDFA 25th Anniversary Award – a major new research grant to support Australian-led research into GA. There is a clear need to prioritise research that addresses critical knowledge gaps in this area.
The Elisabeth Macdonald Memorial Award, announced in the lead up to World Sight Day (9 October 2025) and marking the start of MDFA’s 25th anniversary year, will fund innovative research focused on improving diagnosis, treatment, and support for people living with macular or retinal disease outside major cities.
Celebrating leading macular disease researchers Speech at Macular Disease Foundation Australia’s Research Awards | Governor-General of the Commonwealth of Australia
Celebrating leading macular disease researchers
Driving into the future: strategies to enhance independence for drivers with macular degeneration, including licensing options and the role of modern vehicle technology
Exploring exosomal therapeutics delivery strategies for macular disease
Reducing the risk of end-stage complications of neovascular age-related macular degeneration (AMD): macular atrophy and subretinal fibrosis
Towards a personalised approach to predicting and preventing progression of age-related macular degeneration
Genotype-phenotype correlations in PRPH2-associated retinal dystrophy